KEY FINDINGS The global biosurgery market is forecasted to record a CAGR of 6.32% during the projected period of 2021 to 2028. The market growth is attributed to the rising geriatric population, the incidence of musculoskeletal disorders, technological advancements, and the increasing research and development endeavors.
MARKET INSIGHTS Biosurgical products are characterized as innovative solutions used to treat complex surgical conditions, provide wound sealing, and prevent excessive blood loss. These include anti-adhesive agents, surgical sealants, hemostatic agents, bone-graft substitutes, as well as soft tissue management (mesh/patch) products. As per the data issued by the World Population Prospects: the 2019 Revision, by 2050, 1 in 6 people globally will be over the age of 65 years (16%), indicating an increase from 1 in 11 in 2019 (9%).The surge in the elderly populace has resulted in increased chronic diseases, such as cardiovascular and neurological conditions.
For instance, according to the Health Union data, Parkinson’s disease is the second most common age-related nerve degenerating disorder following Alzheimer’s.The disease affects 5% of the population over age 85 years and 1% of the population over the age of 60 years.
With brain grafting considered the most commonly adopted treatment procedure for Parkinson’s, the increasing geriatric population is set to propel the demand for this treatment procedure.
REGIONAL INSIGHTS The global biosurgery market growth assessment entails the analysis of North America, the Asia-Pacific, Europe, and the Rest of World. North America held the highest market share in 2020, owing to key drivers like the rapid acceptance of technological advancements, the aging population, the growing incidence of chronic diseases, including cardiovascular ailments and cancer, and increasing government funding and investment.
COMPETITIVE INSIGHTS The industrial rivalry within the global biosurgery market is anticipated to be moderate over the forecast years.With a fairly limited number of players, the market’s overall growth is not highly lucrative.
Also, biological products must surpass stringent regulatory pathways. Hence, the competition among existing firms is moderate. Some of the key companies operating in the market are Medtronic PLC, Becton, Dickinson and Company, Sanofi, Baxter International Inc, etc.
Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned 1. BAXTER INTERNATIONAL INC 2. B BRAUN MELSUNGEN AG 3. BECTON, DICKINSON AND COMPANY (C R BARD) 4. BETATECH MEDICAL 5. CSL LIMITED 6. CRYOLIFE INC 7. ETHICON INC (JOHNSON & JOHNSON) 8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION 9. MEDTRONIC PLC 10. RTI SURGICAL 11. SANOFI 12. SMITH & NEPHEW PLC 13. STRYKER CORPORATION 14. WRIGHT MEDICAL GROUP NV 15. ZIMMER BIOMET HOLDINGS INC
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Jul 2021
Major players in the live cell imaging market are Leica Microsystems, Olympus Corporation, Sigma-Aldrich Corporation, PerkinElmer Inc., GE Healthcare, Carl Zeiss Meditec AG, Becton Dickinson and Company, Molecular Devices LLC, Bruker Corporation, Sartorius AG, Oxford Instruments, BioTek Instruments, Etaluma Inc, and CytoSMART Technologies. The...
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
The global hyperspectral imaging systems market exhibited strong growth during 2015-2020. A hyperspectral imaging system can be defined as a technique used to analyze a wide spectrum of light through a spectrometer. The device uses reflected, transferred or emitted light from the object to generate its spectral-based...
The global breakfast food market exhibited moderate growth during 2015-2020. Breakfast food refers to various products that are consumed as the first meal of the day. Some of the most common types of breakfast foods include cereals, bread, eggs, porridge, waffles, pancakes, snack bars, bacon and sausages. They are majorly...
120 pages •
By Infiniti Research Limited
• Jun 2021
Global Biochip Market 2021-2025 The analyst has been monitoring the biochip market and it is poised to grow by $ 25.52 bn during 2021-2025, progressing at a CAGR of almost 23% during the forecast period. Our report on biochip market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges,...
Report Scope The report analyzes the market trends of Minoxidil with data from 2019, estimates from 2020, and projections of compound annual growth rates (CAGRs) through the forecast period of 2020 through 2025). The report will highlight the current and future market potential of Minoxidil along with an analysis of the...
175 pages •
By The Business Research Company
• Jun 2021
Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, Glaxosmithkline, Pfizer, Boehringer Ingelheim, and F. Hoffmann-La Roche. The global protein inhibitors market is expected to grow from $56.97 billion in 2020 to $62.54 billion in 2021 at a compound annual growth rate (CAGR) of 9.8%....
Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations...
U.S. Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Delivery Type (Web-based, Cloud-based, On-premise), By Component, By End Use, By Application, By Therapeutic Area, And Segment Forecasts, 2021 - 2028
U.S. Patient Engagement Solutions Market Growth & Trends
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.